ELOQUENT

Title: A phase 3 randomised trial of Lenalidomide and Dexamethasone with or without Elotuzumab in previously untreated Multiple Myeloma.

Population: Patients not eligible for high dose Treatment & Stem cell transplant due to age (>65) or co-morbities.

Resource Links:

http://clinicaltrials.gov/ct2/show/NCT01335399

https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-022445-20/IE

« Back